Legislation allowing doctor-assisted suicide narrowly clears Delaware House, heads to state Senate

DOVER, Del. — A bill allowing doctor-assisted suicide in Delaware narrowly cleared the Democrat-led House on Thursday and now goes to the state Senate for consideration. The bill is the latest iteration of legislation that has been repeatedly introduced by Newark Democrat Paul Baumbach since 2015, and it is the only proposal to make it … Read more

Biden and Sen. Bernie Sanders join forces to promote lower health care costs, including for inhalers

WASHINGTON — President Joe Biden teamed up with Sen. Bernie Sanders on Wednesday to promote his administration’s efforts to lower the cost of inhalers and other health care needs, as the White House continues its effort to highlight Biden’s legislative achievements to voters ahead of the November elections. “Bernie, you and I have been fighting … Read more

ALS drug will be pulled from US market after study showed patients didn’t benefit

WASHINGTON — The maker of a drug for Lou Gehrig’s disease that recently failed in a large study said Thursday it will pull the medicine from the market, acknowledging it didn’t help patients with the deadly neurological condition. Amylyx Pharmaceuticals announced it will voluntarily halt sales and marketing of the drug in the U.S. and … Read more

Biden is announcing a new rule to protect consumers who purchase short-term health insurance plans

President Joe Biden on Thursday announced new steps to protect consumers who buy short-term health insurance plans that critics say amount to junk. A new rule finalized by the Democratic president’s administration will limit these plans to just three months. And the plans can only be renewed for a maximum of four months, instead of … Read more

Biden and Harris team up for health care event in North Carolina

WASHINGTON — President Joe Biden and Vice President Kamala Harris will promote their health care agenda on Tuesday in North Carolina, a battleground state that Democrats hope to flip in their favor after falling short to Donald Trump in the last two presidential elections. Fourteen years after President Barack Obama signed the Affordable Care Act … Read more

Contraceptives will be available without a prescription in New York following a statewide order

ALBANY, N.Y. — Contraceptives will be available without a prescription in New York under an order signed by state health officials on Tuesday. The move is part of New York Gov. Kathy Hochul’s mission to bolster reproductive rights at a time when its restricted in other parts of the country. The measure comes as the … Read more

A new kind of hospital is coming to rural America. To qualify, facilities must close their beds

As rural hospitals continue to struggle financially, a new type of hospital is slowly taking root, especially in the Southeast. Rural emergency hospitals receive more than $3 million in federal funding a year and higher Medicare reimbursements in exchange for closing all inpatient beds and providing 24/7 emergency care. While that makes it easier for … Read more

Here’s Donald Trump’s Actual Record On Abortion, Obamacare And Drug Prices

This article is part of HuffPost’s biweekly politics newsletter. Click here to subscribe. Donald Trump made some news Monday when the conversation in a seemingly innocuous CNBC interview turned to the national debt, and whether he’d be willing to cut entitlements like Social Security and Medicare to reduce it. “There is a lot you can … Read more

Biden is issuing a budget plan that details his vision for a second term

WASHINGTON — WASHINGTON (AP) — President Joe Biden is issuing a budget plan Monday aimed at getting voters’ attention: tax breaks for families, lower health care costs, smaller deficits and higher taxes on the wealthy and corporations. Unlikely to pass the House and Senate to become law, the proposal for fiscal 2025 is an election-year … Read more

Maker of much-debated ALS drug says it may stop selling it after study showed it didn’t work

WASHINGTON — The maker of a much-debated drug for Lou Gehrig’s disease said Friday its therapy failed to help patients in a large follow-up study, but stopped short of committing to follow through on a prior pledge to pull the drug from the U.S. market. The Food and Drug Administration approved Amylyx Pharmaceuticals’ Relyvrio in … Read more